PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27822214-6	2016	Similar to a well-known immunosuppressive agent cyclosporine A (CsA), Gracilin H, A, L, and tetrahydroaplysulphurin-1 were able to reduce the CD147 membrane expression and to block the release of Cyp A to the medium.	Cyclosporine	48-62	basigin	Mus musculus	142-147	
27822214-6	2016	Similar to a well-known immunosuppressive agent cyclosporine A (CsA), Gracilin H, A, L, and tetrahydroaplysulphurin-1 were able to reduce the CD147 membrane expression and to block the release of Cyp A to the medium.	Cyclosporine	64-67	basigin	Mus musculus	142-147	
22394628-14	2012	Alveolar epithelial cells,  bronchiolar epithelial cells,  mononuclear macrophages,  neutrophils and lymphocytes were demonstrated to express CD147,  there was higher CD147 expression in BLM model group than those in CsA treatment groups.	Cyclosporine	217-220	basigin	Mus musculus	142-147	
22394628-15	2012	CONCLUSION: CsA may heal BLM induced interstitial pulmonary disease by blocking CD147-CypA interaction,  then decreasing chemotaxis for the immunocyte,  and reducing migration of immunocytes to the lung and collagen deposition in the lung.	Cyclosporine	12-15	basigin	Mus musculus	80-85	
15972687-6	2005	Blocking cyclophilin-CD147 interactions by targeting CD147 (using anti-CD147 Ab) or cyclophilin (using nonimmunosuppressive cyclosporine A analog) reduced tissue neutrophilia by up to 50%, with a concurrent decrease in tissue pathology.	Cyclosporine	124-138	basigin	Mus musculus	21-26